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The paa cluster of Escherichia coli W involved in the
aerobic catabolism of phenylacetic acid (PA) has been
cloned and sequenced. It was shown to map at min 31.0
of the chromosome at the right end of the mao region
responsible for the transformation of 2-phenylethyl-
amine into PA. The 14 paa genes are organized in three
transcription units: paaZ and paaABCDEFGHIJK, en-
coding catabolic genes; and paaXY, containing the paaX
regulatory gene. The paaK gene codes for a phenylac-
etyl-CoA ligase that catalyzes the activation of PA to
phenylacetyl-CoA (PA-CoA). The paaABCDE gene prod-
ucts, which may constitute a multicomponent oxygen-
ase, are involved in PA-CoA hydroxylation. The PaaZ
protein appears to catalyze the third enzymatic step,
with the paaFGHIJ gene products, which show signifi-
cant similarity to fatty acid b-oxidation enzymes, likely
involved in further mineralization to Krebs cycle inter-
mediates. Three promoters, Pz, Pa, and Px, driven the
expression of genes paaZ, paaABCDEFGHIJK, and
paaX, respectively, have been identified. The Pa pro-
moter is negatively controlled by the paaX gene prod-
uct. As PA-CoA is the true inducer, PaaX becomes the
first regulator of an aromatic catabolic pathway that
responds to a CoA derivative. The aerobic catabolism of
PA in E. coli represents a novel hybrid pathway that
could be a widespread way of PA catabolism in bacteria.
Escherichia coli living in the animal gut encounters aromatic
compounds such as phenylacetic acid (PA),1 phenylpropionic
acid, and their hydroxylated derivatives, as a result of the
action of intestinal microflora on plant constituents, the amino
acids phenylalanine and tyrosine, fatty acids with a terminal
phenyl substituent, and some of their metabolites (1–3). The
aerobic catabolism of these aromatic compounds by E. coli
could occur close to the epithelial cells in the guts of warm-
blooded animals, as well as in soil, sediment, and water once E.
coli is excreted from its intestinal residence (4). The ability of E.
coli to mineralize 3- and 4-hydroxyphenylacetic acids (5),
3-phenylpropionic, 3-(3-hydroxyphenylpropionic), and 3-hy-
droxycinnamic acids (2, 6), and phenylacetic acid (2, 7) has been
reported previously. Recently, the molecular characterization
of these catabolic pathways, with the only exception of that for
PA degradation, has been carried out (1, 8–11), demonstrating
that E. coli is endowed with its own set of genes and enzymes
for the catabolism of aromatic compounds, and that they are
similar to those of other microorganisms more relevant in the
environment such as bacteria of the genus Pseudomonas.
Although PA is a common source of carbon and energy for a
wide variety of microorganisms, the bacterial catabolism of this
natural aromatic compound is still poorly understood (12, 13).
Earlier reports suggested that aerobic PA catabolism impli-
cated the typical initial attack by hydroxylation of the aromatic
ring with the formation of the corresponding 2,5- or 3,4-dihy-
droxyphenylacetate as intermediates (13). However, much of
this evidence was circumstantial, and none of the typical aer-
obic routes that could explain PA degradation were responsible
of this catabolism in different PA-degrading bacteria (13, 14).
According to these data, it has been recently shown that
Pseudomonas putida U mineralizes PA aerobically through a
novel catabolic pathway, which does not follow the conven-
tional routes for the aerobic catabolism of aromatic compounds
and whose first step is the activation of PA to phenylacetyl-
coenzyme A (PA-CoA) by the action of a PA-CoA ligase (12, 15).
In this sense, the participation of a PA-CoA ligase in the aer-
obic catabolism of PA has been also inferred from its specific
induction during growth on PA of different bacterial strains
(13, 16).
Here we present the cloning, genetic characterization, mech-
anism of regulation, and a partial biochemical characterization
of the PA biodegradation pathway from E. coli W. This work
reveals that the PA degradation in E. coli follows an unusual
route for the aerobic catabolism of aromatic compounds, which
involves CoA derivatives. With the molecular characterization
of the paa-encoded pathway, all aromatic catabolic routes so far
reported in E. coli are now described at the molecular level.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions—The E. coli
strains used were E. coli W ATCC11105 (17); E. coli W14 (18); E. coli C
(8); and the E. coli K-12 strains MV1190 (19), C600 (20), TG1 (20),
ET8000 (21), W3110 (20), MG1655 (11), HB101 (20), DH1 (20), CC118
(1), DH5a (20), JM109 (20), and S17–1lpir (22). E. coli W14Rif (this
work) is a spontaneous rifampicin-resistant mutant from E. coli W14; E.
coli AF141 (this work) is a lacZ2 mutant obtained from the E. coli
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W14Rif strain by N-methyl-N9-nitro-N-nitrosoguanidine treatment as
described by Miller (23). For cloning and expression purposes we have
used two chloramphenicol-resistant low copy number cloning vectors,
plasmids pCK01 (1) and pSJ19Not (like pCK01 but containing the
polylinker region from pUC19), as well as pUC18, pUC19 (20), and
pUC18Not (22) vectors. The promoter-probe pSJ3 vector is a pUJ9
derivative (22) bearing a 85-bp SmaI/BamHI fragment that contains
the 59-leader region of IS10 transposase (19). To integrate the lacZ
fusions into the chromosome, plasmid pUTmini-Tn5Km2 was used (22).
Unless otherwise stated, bacteria were grown in Luria-Bertani (LB)
medium (20) at 37 °C. When used as carbon sources, PA and/or glycerol
were supplied at 5 and 20 mM, respectively, to M63 minimal medium
(23) containing the corresponding necessary nutritional supplements,
and the cultures were incubated at 30 °C. Where appropriate, antibiot-
ics were added at the following concentrations: ampicillin (100 mg/ml),
chloramphenicol (35 mg/ml), kanamycin (50 mg/ml), and rifampicin (50
mg/ml).
DNA Manipulations and Sequencing—Plasmid DNA was prepared
by the rapid alkaline lysis method (20). Transformation of E. coli was
carried out using the RbCl method (20). DNA manipulations and other
molecular biology techniques were essentially as described (20). DNA
fragments were purified by using low melting point agarose. Southern
blot analyses were performed as previously reported (20), using as
probes DNA fragments labeled with [a-32P]dCTP by the random primer
method (Amersham Pharmacia Biotech). Pulsed-field gel electrophore-
sis of total DNA from E. coli W was carried out as described (24).
Oligonucleotides were synthesized on an Oligo-1000M nucleotide syn-
thesizer (Beckman Instruments, Inc.). Nucleotide sequences were de-
termined directly from plasmids by using the dideoxy chain termination
method (25). Standard protocols of the manufacturer for Taq DNA
polymerase-initiated cycle sequencing reactions with fluorescently la-
beled dideoxynucleotide terminators (Applied Biosystems Inc.) were used.
The sequencing reactions were analyzed using a model 377 automated
DNA sequencer (Applied Biosystems Inc.). Sequences were extended by
designing primers based on the previously determined sequence.
Sequence Data Analyses—Nucleotide sequence analyses were done
with the DNA-Strider 1.2 program. Amino acid sequences were ana-
lyzed with the Protein Analysis Tools at the ExPASy World Wide Web
molecular biology server of the Geneva University Hospital and the
University of Geneva. Nucleotide and protein sequence similarity
searches were made by using the BLASTP, BLASTN, and BLASTX
programs (26) via the National Institute for Biotechnology Information
server. Pairwise and multiple protein sequence alignments were made
with ALIGN (27) and CLUSTAL W (28) programs, respectively, at the
Baylor College of Medicine-Human Genome Center server. The E. coli
data base collection ECDC (29) was accessed via the Internet.2
Cloning and Expression of the Pa, Px, and Pz Promoter Regions—The
Pa424 promoter region was PCR-amplified from plasmid pAAD by using
primers PZ5 (59-GGGGTGAATCAAACGGCTACG-39; the sequence cor-
responds to nucleotides 2402–2420 in Fig. 2) and PA5–1 (59-
CAATCTCGGAATGCGCATG-39; the sequence corresponds to nucleo-
tides 2885–2867 in Fig. 2). The resulting 495-bp DNA fragment was
digested with KpnI and SphI and cloned as a 424-bp fragment into the
double-digested KpnI1SphI pSJ3 vector to form plasmid pAFPA1 (Fig.
5). The Pa255 promoter region was PCR-amplified by using primers PAP
(59-GGTCTAGAGTTATCAAAATAGAGTGCG-39; the sequence corre-
sponds to nucleotides 2611–2631 in Fig. 2; engineered XbaI restriction
site is underlined) and PA5–1. The resulting 272-bp DNA fragment was
digested with XbaI and SphI and cloned as a 255-bp fragment into the
double-digested XbaI1SphI pSJ3 vector to form plasmid pAFPA2 (Fig.
5). The Pz promoter region was PCR-amplified by using primers PZ5–1
(59-GGGGATCCCGGCCAGACTGCCAGGTAC-39; the sequence corre-
sponds to nucleotides 2423–2443 in Fig. 2; engineered BamHI restric-
tion site is double-underlined) and PA5–1. The resulting 474-bp DNA
fragment was digested with SphI and BamHI and cloned as a 446-bp
fragment into the double-digested SphI1BamHI pSJ3 vector to form
plasmid pAFPZ (Fig. 5). The Px promoter region was PCR-amplified by
using primers 5,5f2 (59-CCGCATGGATCGCATCAGC-39; the sequence
corresponds to nucleotides 11910–11928 in Fig. 2) and PX5–2 (59-
GGGGATCCGAATCACCATACAGAGAGGAG-39, the sequence corre-
sponds to nucleotides 12456–12436 in Fig. 2; engineered BamHI site is
double-underlined). The resulting 554-bp DNA fragment was digested
with SspI and BamHI, and cloned as a 214-bp fragment into the
double-digested SmaI1BamHI pSJ3 vector to form plasmid pAFPX
(Fig. 5).
Tn1000 Transposition Mutagenesis of paa Genes—Transposition
with Tn1000 was carried out according to the previously described
method (30). The pAAD plasmid was mutagenized with Tn1000 by
selecting for conjugative transfer of this plasmid from the recA F1 donor
strain E. coli MG1063 to the F2 recipient strain E. coli CC118. Before
mating, both parents were grown at 37 °C, without shaking, to an
optical density at 600 nm of about 0.5. Two milliliters of donor cells and
one milliliter of recipient cells were mixed and incubated at 37 °C
without shaking for 2 h. After addition of 12 ml of LB medium and
further incubation with vigorous shaking for 3 h, exconjugants were
selected on LB medium containing rifampicin and chloramphenicol.
The pAAD derivatives bearing Tn1000 insertions within the paa genes
were further analyzed. The primer Tn5900 (59-AAAAGGGGAACT-
GAGAGCTC-39) that hybridized with the d terminus of transposon
Tn1000 was used to sequence the insertion sites.
Construction of E. coli AF1411 and AF1412 Strains—By means of
RP-4 mediated mobilization, the plasmids pAFPA1T and pAFPA2T,
which contain mini-Tn5 hybrid transposons expressing Pa-lacZ fusions
(Fig. 5), were transferred from E. coli S17–1lpir into E. coli AF141.
Filter matings were performed as described previously (22). Exconju-
gants containing the lacZ translational fusions stably inserted into the
chromosome, E. coli AF1411 and E. coli AF1412, were selected for the
transposon marker, kanamycin, on rifampicin-containing LB medium.
Determination of the Transcription Start Sites by Primer Exten-
sion—E. coli CC118 cells containing plasmids pAFPA1, pAFPA2,
pAFPZ, pAFPX, or pSJ3 (Fig. 5), were grown in minimal medium
containing glycerol and PA until the cultures reached an optical density
at 600 nm of about 1.0. Total RNA was isolated using the Qiagen
RNA/DNA Midi Kit (Qiagen) according to the instructions of the sup-
plier. Primer extension reactions were carried out with the avian my-
eloblastosis virus reverse transcriptase as described previously (31),
using primers LAC-57 (59-CGATTAAGTTGGGTAACGCCAGGG-39,
which hybridized at 57 nucleotides downstream of the lacZ start codon)
and PA5–4 (59-CGGGCATCCAGTCCTGTGGCTCG-39, which hybrid-
ized at 55 nucleotides downstream of the paaA start codon). Products
were analyzed on 6% polyacrylamide-urea gels.
Resting Cell Reactions—E. coli W14 cells harboring different
pAAD::Tn1000 derivatives were grown in minimal medium containing
glycerol and PA to an optical density at 600 nm of about 0.8. Cell
cultures were then centrifuged (3,000 3 g, 10 min at 20 °C), and cells
were washed and resuspended in a 0.05 volume of minimal medium.
The resting cell reactions were performed in a final volume of 5 ml
containing 4.5 ml of M63 minimal medium and 0.5 ml of the cell
suspension. The reaction was started by the addition of 1 mM PA, and
the tubes were incubated on a rotary shaking platform at a temperature
of 30 °C. Samples of 0.5 ml were taken at different times and centri-
fuged (10,000 3 g, 5 min) to remove the cells.
To detect the accumulation of intracellular intermediates in PA
catabolism, E. coli W14 (pAFK5) and E. coli W14 (pAAD::Tn1000 de-
rivatives) cells were grown in LB medium containing 0.2 mM isopropyl-
1-thio-b-D-galactopyranoside and minimal medium containing glycerol
and PA, respectively. When the cultures reached an optical density at
600 nm of about 1.0, cells were centrifuged, washed as described above,
and resuspended in 0.005 volume of minimal medium supplemented
with 10 mM glucose. The reaction was started by the addition of 50 mM
[1-14C]PA (4 mCi/ml) (Sigma) and incubated for 5 min at 30 °C. The
following treatments were performed at 4 °C. Cells were centrifuged,
washed with minimal medium containing 10 mM glucose, and resus-
pended in 0.01 volume of 0.5 M HClO4. After vortexing vigorously for 1
min, the sample was frozen and thawed once and then centrifuged
(10,000 3 g, 5 min). While the supernatant was collected, the sediment
was treated again with 0.01 volume of 0.5 M HClO4. Finally, the two
supernatants were mixed, filtered through cellulose-triacetate mem-
brane filters (10,000 Mr) (Alltech Associates, Inc.), vacuum-dried, and
resuspended in 200 ml of H2O.
Phenylacetyl-Coenzyme A Ligase Assay—E. coli W14 cells containing
different pAAD derivatives were grown overnight in minimal medium
containing glycerol and vitamin B12 (500 ng/ml) in the presence or
absence of PA, and then diluted into fresh medium to an optical density
of about 0.1. Growth was resumed at 30 °C until the cultures reached an
optical density at 600 nm of about 1.0. Cells were harvested by centrif-
ugation, washed, and resuspended in 0.05 volume of 0.5 M potassium
phosphate buffer, pH 8.2, prior to disruption by passage through a
2 The programs listed are available via the Internet: Protein Analysis
Tools (http://EXPASY.HCUGE.CH./www/tools.html); BLASTP, BLASTN,
and BLASTX programs (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST);
ALIGN and CLUSTAL W programs (http://kiwi.imgen.bcm.tmc.edu:
8088/search-launcher/launcher.html); and the E. coli data base collec-
tion ECDC (http://susi.bio.uni-giessen.de/ecdc.html).















French press (Aminco Corp.) operated at a pressure of 20,000 p.s.i. The
cell debris was removed by centrifugation at 26,000 3 g for 30 min. The
clear supernatant fluid was carefully decanted and used as crude ex-
tract. Protein concentration was determined by the method of Bradford
(32) using bovine serum albumin as standard. Phenylacetyl-coenzyme
A ligase was assayed as described previously (33). One unit of enzyme
activity is defined as the catalytic activity leading to the formation of 1
nmol of phenylacetylhydroxamate in 1 min at 37 °C.
b-Galactosidase Assay—b-Galactosidase activities were measured
with permeabilized cells from cultures grown to mid-log phase, as
described by Miller (23).
Analytical Methods—The N-terminal sequence of PaaK was deter-
mined by Edman degradation with a model 477A automated protein
sequencer (Applied Biosystems Inc.). The protein was directly electro-
blotted from a SDS-polyacrylamide gel onto a polyvinylidene difluoride
membrane as described previously (18).
The metabolites accumulated in the supernatants of resting cells and
in culture supernatants, were analyzed with a Gilson HPLC equipment
using a Lichrosphere 5 RP-8 column (150 3 4.6 mm) and an isocratic
flow of a 40% methanol-H2O mobile phase pumped at a flow rate of 1
ml/min. Peaks with retention times of 5.6 and 10.6 min, corresponding
to those of authentic standard 2-HPA and PA, respectively, were mon-
itored at 220 nm.
The intracellular 14C-labeled metabolites accumulated in resting cell
assays were analyzed with the HPLC equipment described above but
using an isocratic flow of 0.2 M KH2PO4 (pH 4.2), isopropyl alcohol (92:8,
v/v) as mobile phase pumped at a flow rate of 1 ml/min. Samples (400 ml)
were collected, and 14C-labeled products were detected in aliquots of the
fractions by liquid scintillation counting. Peaks with retention times of
11.2 and 20.2 min, corresponding to those of authentic standard PA and
PA-CoA, respectively, were monitored at 220 nm.
Thin-layer chromatography was carried out on 0.2-mm Silica gel 60
F254 plates (Merck) with chloroform-acetone (2:1, v/v) as solvents. Ra-
diolabeled compounds were visualized by autoradiography.
The 2-HPA was extracted from culture supernatants with an equal
volume of ethyl acetate and dried with sodium sulfate. Samples were
derivatized with N, O-bis(trimethylsilyl)trifluoroacetamide and sub-
jected to gas chromatography-mass spectrometry analysis as described
elsewhere (34).
RESULTS
Identification of the paa Genes for the Catabolism of PA—We
had recently reported the isolation of an E. coli W mutant,
strain W14, unable to grow on PA and 2-phenylethylamine as
the sole carbon and energy source (18). A recombinant plasmid,
pFA2, which contains a 33.3-kb BamHI DNA insert from the
chromosome of the wild-type E. coli W strain (Fig. 1A), had
been also constructed and was able to confer to E. coli W14 the
ability to grow on either PA or phenylethylamine as the sole
carbon source (18). When the HindIII-digested total DNA from
E. coli W14 and E. coli C, a strain also unable to grow on PA as
the sole carbon source (2), was analyzed by Southern blot using
the 33.3-kb BamHI fragment of pFA2 as probe, no hybridiza-
tion bands were observed (data not shown). These results in-
dicated that E. coli strains W14 and C have a deletion encom-
passing at least the 33.3-kb DNA fragment cloned in pFA2, and
therefore it is likely that they lack the genes involved in PA
catabolism (paa genes). Moreover, we have observed that,
whereas the E. coli K-12 strains MV1190, C600, TG1, ET8000,
W3110, and MG1655 grew on PA, the K-12 strains HB101,
DH1, CC118, DH5a, and JM109 did not grow on this aromatic
compound. A Southern blot analysis of the HindIII-digested
total DNA from E. coli K-12 PA1 (W3110, MG1655, and C600)
and PA2 (DH5a, HB101, and DH1) strains revealed the same
pattern of hybridization bands, thus suggesting that the PA2
phenotype in E. coli K-12, in contrast to that in E. coli W14 and
E. coli C, could be produced by point mutations or small dele-
tions or insertions. Interestingly, all E. coli PA2 strains were
able to grow on this aromatic compound when harboring plas-
mid pFA2, and the loss of this plasmid after several rounds of
cultivation of the recombinant strains in the absence of selec-
tive pressure was also accompanied by the loss of the PA1
phenotype.
FIG. 1. Genetic organization of the paa genes responsible of the catabolism of PA in E. coli, and locations of Tn1000 insertions. A,
physical and genetic map of the chromosomal region containing the paa genes, and different cloned DNA fragments. Locations of the genes are
shown relative to those of some relevant restriction sites. Arrows indicate the direction of gene transcription. Enlarged is shown the paa cluster
(black box). In plasmid pFA2 the nucleotide sequence of the vector (pBR322) is represented by the dotted box. Plasmids containing different
subcloned DNA fragments (the sizes of the inserts are shown on the top) are indicated with continuous (pUC derivatives) or discontinuous (pCK01
derivatives) lines. The open arrowheads represent the Plac promoter. B, locations of transposon Tn1000 in pAAD-derived mutant plasmids. The
15.4-kb DNA insert in plasmid pAAD is represented with a striped box. The g-d and d-g orientations of Tn1000 insertions are shown by . and ,
symbols, respectively. Insertions which affect (filled symbols) or do not affect (empty symbols) catabolic functions are indicated. D, a truncated gene.
Cmr, the gene that confers chloramphenicol resistance. Restriction sites are: B, BglII; Ba, BamHI; E, EcoRI; Ev, EcoRV; H, HindIII; N, NotI; P,
PstI; Sm, SmaI.















As several aromatic catabolic pathways are encoded by plas-
mids and E. coli W was shown to host cryptic plasmids (35), it
was checked whether the paa genes were also located in a
plasmid. When a pulse field electrophoresis of unrestricted
total DNA from E. coli W was analyzed by Southern blot using
the 33.3-kb DNA fragment as probe, hybridization signals were
only found in the sample wells (data not shown), thus indicat-
ing a chromosomal location (36) of the paa genes.
To localize the paa genes within the cloned 33.3-kb DNA
fragment, its physical map was determined and different sub-
clones were constructed (Fig. 1A) and checked for their ability
to restore the growth of E. coli W14 on PA-containing minimal
medium. Interestingly, although plasmids pFCP142 and
pFCH112 (Fig. 1A) did not confer to E. coli W14 the ability to
grow on PA, plasmid pAAD restored the growth of strain W14
on this aromatic compound, thus locating the paa genes in a
15.4-kb DNA fragment at the right end of the previously iden-
tified mao region (Fig. 1A) responsible of the transformation of
2-phenylethylamine into PA (18, 37, 38).
Sequencing and Gene Arrangement of the paa Cluster—To
genetically characterize the PA catabolic pathway of E. coli W,
the 15.4-kb insert of plasmid pAAD (Fig. 1A) was sequenced.
The nucleotide sequence of a 14,328-bp region of this insert is
shown in Fig. 2. Computer analysis of this sequence revealed
the presence of 14 ORFs, all of which are transcribed in the
same direction with the sole exception of paaZ (Figs. 1 and 2).
Data bases were searched for similar proteins to the paa gene
products, and those showing the highest similarity values were
then retrieved and compared (Table I). The putative Shine-
Dalgarno sequences of paaFGHIJ and paaY overlap the pre-
ceding ORFs (Fig. 2), suggesting that the most common mech-
anism of translational coupling (39) may occur. Downstream of
the paaZ, paaK, and paaY genes we found inverted repeat
sequences (Fig. 2) predicted to form hairpin loops with DG
values of 213.4, 225.3, and 215.7 kcal/mol, respectively, which
could act as transcriptional terminators. The G1C content of
the paa cluster averaged 52.5%, a value close to the mean G1C
content of E. coli genomic DNA (51.5%) (40). At the 39-end of
the sequenced fragment, a partial ORF corresponded to the
59-end of ydbC (Fig. 2), a gene of unknown function from E. coli
K-12 (29, 41).
To define the essential genes required for PA catabolism in
E. coli W, transposon mutagenesis of the 15.4-kb NotI-DNA
cassette in pAAD was carried out. A collection of Tn1000 in-
sertion derivatives was obtained, and to determine the physical
location and orientation of each insertion in pAAD::Tn1000
mutant plasmids, DNA from each derivative was isolated and
analyzed by cleavage with different restriction enzymes. In
most of the cases, the sites of the Tn1000 insertions were
sequenced with a primer that hybridized with the d terminus of
transposon Tn1000. Twenty different Tn1000 insertions were
identified and checked for their ability to avoid the growth on
PA of E. coli W14 harboring the corresponding pAAD::Tn1000
derivatives (Fig. 1B). On the basis of these studies, it was
shown that only Tn1000 insertions within genes paaX and
paaY did not affect PA catabolic functions, suggesting that the
12 remaining paa genes were essential for the catabolism of
this aromatic compound (Fig. 1B).
Analysis of PA Pathway Intermediates—To identify possible
intermediates of the PA catabolic pathway in E. coli W, we first
checked the capability of this organism to grow on different
aromatic compounds that were thought to be produced during
PA degradation, e.g. benzoate, phenylpyruvate, p-hydroxyphe-
nylpyruvate, mandelate, and phenylglyoxylate. The strain was
patched onto PA-containing mineral agar plates to induce the
PA pathway, and then replicated onto mineral agar plates
containing the aromatic compounds at a concentration of 5 mM.
As none of the compounds tested allowed the growth of E. coli
FIG. 2. Nucleotide and derived
amino acid sequences of the PA cata-
bolic pathway. Only the sequences of
the 59- and 39-end coding regions of the
paa genes are shown. The 59-end coding
regions of the maoA and ydbC genes are
also indicated. The BglII restriction site
at the 59-end of the sequence is shown.
Amino acids are represented by their
standard one-letter code. Short arrows
show the direction of gene transcription.
Asterisks indicate stop codons. Boldface
nucleotides represent potential Shine-
Dalgarno sequences. Putative transcrip-
tional terminators are underlined. #, a
transcription start site. Sequences of po-
tential 210 and 235 boxes are shown in
italics. Inverted repeats in promoter re-
gions are marked with convergent arrows
underneath the sequence. A sequence
that shows good similarity to the core con-
sensus integration host factor-binding
motif (1) is double-underlined.















W, they appeared not to be intermediates in PA catabolism.
To check whether the different pAAD::Tn1000 derivatives
caused accumulation of PA pathway intermediates, E. coli W14
cells harboring these plasmids were grown in minimal medium
containing PA and glycerol. Supernatants of the cultures were
then analyzed by HPLC, revealing that only the clones contain-
ing plasmids with Tn1000 insertions in genes paaX, paaY, and
paaZ, showed PA consumption. However, although disruptions
of genes paaX and paaY did not cause the accumulation of any
compound, disruption of the paaZ gene caused the conversion
of PA into a metabolite whose retention time in HPLC was
identical to that of standard 2-HPA. Gas chromatography-mass
spectrometry analysis confirmed this metabolite as 2-HPA
(data not shown). Similar results were obtained when resting
cell assays of the paaZ insertion mutants were performed in
the presence of 1 mM PA and then analyzed by HPLC (Fig. 3A).
These data were also in agreement with the observation that
plasmid pFCP142, which contains the paa cluster with a trun-
cated paaZ gene (Fig. 1A), conferred to E. coli W14 cells the
ability to transform PA into 2-HPA.
To analyze whether 2-HPA was an intermediate in PA deg-
radation, E. coli W cells were grown in PA-containing minimal
medium and then inoculated into minimal medium containing
2-HPA as the sole carbon source; however, this compound did
not support bacterial growth. Moreover, E. coli W cells grown in
minimal medium containing both PA and 2-HPA did not attack
the latter compound, as observed by HPLC analysis of the
culture supernatants. Therefore, these data suggested that
2-HPA could be a product derived from an unstable intermedi-
ate rather than a true intermediate of the PA catabolic path-
way. As it has been shown that the cis-dihydrodiols formed
during the catabolism of different aromatic compounds readily
dehydrate nonenzymatically under acidic conditions leading to
the corresponding monohydroxy derivatives (2, 42), we checked
whether 2-HPA could be also the product of dehydration of a
dihydrodiol by monitoring the reported spectral changes asso-
ciated with such decomposition (42). However, the UV spec-
trum of the supernatants from E. coli W14 cells containing the
pAAD::Tn1000 derivative 3 (Fig. 1B) did not show any change
under acidic conditions, suggesting that a putative dihydrodiol
of PA was not present in the culture medium.
As analyses of culture supernatants did not reveal any true
intermediate in PA catabolism, intracellular accumulation of
possible metabolites was monitored by thin-layer chromatog-
raphy of resting cell assays of E. coli W14 (pAAD::Tn1000)
mutants in the presence of radioactive [14C]PA. It was observed
that only mutations in the paaZ gene caused incorporation of
radioactivity into the cells. To identify the radioactive products
accumulated, extracts of E. coli W14 (pAAD::Tn1000 derivative
3) were analyzed by HPLC and the detected radioactive peaks
were shown to cochromatograph with authentic PA and PA-
CoA (data not shown). Furthermore, radioactive 2-HPA was
detected by HPLC analysis of the supernatants derived from E.
coli W14 (pAAD::Tn1000 derivative 3) in resting cell assays.
TABLE I
PA pathway genes, their products, and related gene products
Gene Gene product(Da/aa)a Prosite signature
Related gene products
Name Function Organism % Identity/aa Accessionno.
paaZ 73,045/681 MaoC Putative regulator K. aerogenes 78.7 /335 (336–681)b P49251
NodN Unknown R. leguminosarum 28.3 /161 (545–681) P08634
BadH Betaine-aldehyde DHc B. vulgaricus 24.5 /500 (1–527) P28237







TdnB Aniline dioxygenase reductase P. putida 30.1 /337 D85415
TsaB Toluenesulfonate monooxygenase
reductase
C. testosteroni 28.3 /317 U32622




Echm Enoyl-CoA hydratase R. norvegicus 41.7 /290 P14604
BadK Cyclohexene carboxyl-CoA hydratase R. palustris 40.3 /226 U75363
Crt Crotonase C. acetobutylicum 37.8 /261 P52046
ORF257 Enoyl-CoA hydratase homologue R. capsulatus 36.2 /257 P24162
CaiD Carnitine racemase E. coli 31.0 /297 P31551
paaG 28,450/262 ORF257 Enoyl-CoA hydratase homologue R. capsulatus 44.9 /257 P24162
Crt Crotonase C. acetobutylicum 31.3 /261 P52046
BadK Cyclohexene carboxyl-CoA hydratase R. palustris 34.0 /226 U75363
Echm Enoyl-CoA hydratase R. norvegicus 29.7 /290 P14604
paaH 51,704/475 3-hydroxyacyl-
CoA DHc
Hbd 3-hydroxybutyryl-CoA DHc C. acetobutylicum 43.3 /282 (1–289) M31799
Schad 3-hydroxyacyl-CoA DHc H. sapiens 38.1 /314 (1–289) X96752
paaI 14,850/140 ComA Competence protein B. subtilis 25.5 /126 P14205
YbdB Unknown E. coli 21.9 /137 P15050
FcbC Thioesterase Arthrobacter sp. 20.4 /151 M93187
paaJ 42,276/401 Thiolase PcaF b-ketoadipyl-CoA thiolase P. putida 66.1 /400 U10895
CatF b-ketoadipyl-CoA thiolase A. calcoaceticus 61.3 /401 M76991
Thil Acetyl-CoA acetyltransferase C. acetobutylicum 45.3 /392 U08465
paaK 48,966/437 AMP-binding FtsA Coenzyme F390 synthetase M. thermoautotrophicum 24.9 /377 X92347
FcbA 4-Cl-benzoate-CoA ligase Arthrobacter sp. 20.8 /522 M93187
paaX 35,266/316
paaY 21,439/196 Transferase CaiE Unknown E. coli 56.7 /203 P39206
Fbp Ferripyochelin binding protein P. aeruginosa 33.7 /174 P40882
a aa, amino acid.
b In parentheses is indicated the partial amino acid sequence of the paa gene product that has been used for comparison.
c DH means dehydrogenase.















Therefore, all these data taken together suggest that 2-HPA is
secreted to the culture medium when the catabolism of PA is
blocked, CoA derivatives such as PA-CoA being the true inter-
mediates of the pathway.
The paaK Gene Encodes a PA-CoA Ligase—The formation of
PA-CoA during the catabolism of PA in E. coli W suggests the
existence of a PA-CoA ligase activity involved in the activation
of PA to its CoA derivative. As the derived amino acid sequence
of the paaK gene product revealed a putative AMP-binding
consensus motif (Table I), and showed a high identity to that of
the PhaE, former Pcl (65.6%), and PaaK_Y2 (67.3%) proteins
responsible for the conversion of PA to PA-CoA in P. putida U
(12) and Pseudomonas sp. Y2 (16), respectively, we assumed
that PaaK could be the PA-CoA ligase of E. coli W. To experi-
mentally demonstrate that paaK encoded a PA-CoA ligase, this
gene was subcloned in plasmid pUC19 under the control of the
lac promoter resulting in plasmid pAFK5 (Fig. 4A). Crude
extracts of E. coli W14 (pAFK5) cells grown in glycerol-contain-
ing minimal medium showed a high level of PA-CoA ligase
activity (450 units/mg protein), and this activity was dependent
on the presence of ATP, CoA, and PA. SDS-polyacrylamide gel
electrophoresis analysis of crude lysates from these cells re-
vealed the presence of an intense band corresponding to a
protein with an apparent molecular mass of 49 kDa (data not
shown), which is in good agreement with the predicted molec-
ular mass for the PaaK protein (Table I). The N-terminal se-
quence, MITNTK, of the overproduced protein corresponded
with that deduced from the nucleotide sequence of the paaK
gene, thus confirming it as the paaK gene product and showing
that no processing of its N-terminal end occurs.
To demonstrate that the product of the reaction catalyzed by
PaaK was PA-CoA, we performed resting cell assays of E. coli
W14 (pAFK5) in the presence of [14C]PA. Two radioactive
peaks that cochromatographed with authentic PA and PA-CoA
were observed (Fig. 3B). To confirm that the second radioactive
peak corresponded to PA-CoA, we performed the hydrolytic
removal of the CoA moiety by treatment of the sample with
NaOH at 65 °C for 30 min, and, as expected, the resulting 14C-
labeled product was shown to elute in HPLC as standard PA.
Analyses of crude extracts of E. coli W14 (pAAD::Tn1000)
mutants grown in minimal medium containing PA and glycerol
revealed that insertions of transposon Tn1000 in genes paaB,
paaC, paaD, paaE, paaF, paaG, and paaJ caused a significant
decrease in the PA-CoA ligase activity, such activity being
below detection limits when the Tn1000 insertions were located
within the paaK gene (Table II). These results may indicate
that genes paaABCDEFGHIJK constitute an operon and that
insertions of transposon Tn1000 within this operon exert
strong polar effects on the genes located downstream of the
insertion site. In agreement with this hypothesis, Tn1000 in-
sertions in genes paaZ, paaX, and paaY did not reduce the
PA-CoA ligase activity of the corresponding mutants (Table II).
Functional Organization of the paa Genes—To study the
functional organization of the paa genes within the PA cata-
bolic pathway, plasmids pAFK3 (paaK), pAFZ1 (paaZ), pFB67
(paaZpaaABCDE), pAFAF1 (paaABCDE), and pAFFK (paaF-
GHIJKpaaXY) (Figs. 1 and 4), were constructed. E. coli W14
cells harboring these plasmids were grown in minimal medium
containing both glycerol and PA, and the supernatants of the
cultures were analyzed by HPLC. We could only observe PA
consumption when genes paaABCDE were expressed simulta-
neously to the paaK gene. Thus, E. coli W14 (pAFK5, pAFAF1)
cells removed PA with the concomitant accumulation of 2-HPA
in the culture medium (data not shown). However, PA re-
mained unaltered in the culture medium when E. coli W14 cells
containing plasmid pAFK5, pAFAF1, pAFFK, pAFZ1, or
pFB67 were analyzed. Therefore, these results indicate that all
or some of the paaABCDE genes are involved in 2-HPA forma-
tion and that this hydroxylation reaction requires the expres-
sion of the paaK gene responsible of PA-CoA formation. As
2-HPA is not a true intermediate in the PA catabolic pathway,
it can be assumed that after the first catabolic step in the PA
degradation, i.e. activation to PA-CoA, a hydroxylation reaction
occurs leading to the formation of a hydroxylated derivative of
PA-CoA. A blockade in the PA degradation pathway preventing
further catabolism of the hydroxylated PA-CoA derivative
could cause the secretion of the latter to the culture medium as
2-HPA.
Although the simultaneous expression of the paaABCDE
and paaK genes gave rise to 2-HPA, the additional presence of
the paaZ gene did not reveal accumulation of 2-HPA in the
supernatants of E. coli W14 (pFB67, pAFK3) cultures. There-
fore, these data suggest that the paaZ gene product could be
responsible of the third enzymatic step in the aerobic catabo-
lism of PA in E. coli W, genes paaFGHIJ being likely involved
in further catabolism of PA to Krebs cycle intermediates.
Regulation of the paa Cluster—Analysis of the paaK expres-
sion showed that the paa-encoded pathway was inducible.
Thus, although crude extracts of E. coli W14 (pAAD) cells
grown in glycerol-containing minimal medium in the absence of
PA did not reveal PA-CoA ligase activity, a significant level of
PaaK activity was observed when the cells were grown in
minimal medium containing glycerol and PA (Table III). Inter-
estingly, extracts from E. coli W14 (pAAD::Tn1000 derivatives
FIG. 3. HPLC chromatograms of the formation of 2-HPA and
PA-CoA from PA in resting cell assays. A, time course of PA con-
sumption and 2-HPA formation in the supernatants of the resting cell
assays from E. coli W14 (pAAD::Tn1000 derivative 3). Assays were
performed as described under “Experimental Procedures.” Samples (20
ml) were retrieved after 0, 2, 8, and 24 h, and analyzed by HPLC as
indicated under “Experimental Procedures.” B, conversion of [14C]PA to
[14C]PA-CoA in E. coli W14 (pAFK5) resting cell assays. The elution
profile of 14C-cellular labeled compounds separated by HPLC is shown.
For details, see “Experimental Procedures.”















6 and 32) cells grown in the presence of PA showed levels of
PA-CoA ligase activity similar to those of extracts from the
same cells grown in the absence of PA (Table III), thus indicat-
ing that Tn1000 insertions in gene paaX cause a constitutive
expression of the paa-encoded pathway. However, no constitu-
tive expression of the paaK gene was observed when paaY was
disrupted by Tn1000 insertion (Table III). Therefore, these
data suggest that the paaX gene product behaves as a negative
regulator of the paa catabolic genes.
The arrangement of the paa genes and the polar effects
derived from the Tn1000 insertions in the paa cluster suggest
the existence of three transcription units, two of them, paaZ
and paaABCDEFGHIJK, responsible of catabolic functions,
and a third one, paaXY, involved in regulation. To study the
promoter regions of the paa cluster, DNA fragments containing
the potential Pz, Pa, and Px promoters of genes paaZ, paaAB-
CDEFGHIJK, and paaXY, respectively, were PCR-isolated and
ligated to the lacZ gene of the promoter-probe vector pSJ3. The
resulting translational fusion plasmids pAFPA1 (Pa424-lacZ,
Pa424 being a 424-bp DNA fragment containing Pa), pAFPA2
(Pa255-lacZ, Pa255 being the Pa424 fragment lacking 169 bp at
its 59-end), pAFPZ (Pz-lacZ), and pAFPX (Px-lacZ) (Fig. 5),
conferred to the host strain E. coli CC118 the ability to produce
blue colonies on media containing the b-galactosidase indicator
5-bromo-4-chloro-3-indolyl b-D-galactopyranoside, thus indicat-
ing the presence of a functional promoter in the four cloned
fragments.
To determine the transcription initiation sites in the Pa, Pz,
and Px promoters, primer extension analyses were performed
with total RNA isolated from E. coli CC118 cells containing
plasmids pAFPA1, pAFPX, and pAFPZ (Fig. 6). The transcrip-
tion initiation sites of the paaA gene were mapped utilizing two
different primers (Fig. 6, A and B), and potential 210 (TG-
TAAC) and 235 (TTGTGA) boxes typical of s70-dependent
promoters were identified in the Pa promoter region (Fig. 2).
The same results were obtained when plasmid pAFPA2 (Pa255-
lacZ) was used as source of RNA for the primer extension
analyses (data not shown). The transcription initiation site in
the Pz promoter (Fig. 6C) was located 27 nucleotides upstream
of the ATG translation initiation codon of the paaZ gene, show-
ing a putative 210 box (TTTAAC) but lacking a consensus 235
sequence (Fig. 2). Analysis of the 194-bp region between the
transcription start sites of the paaZ and paaA genes showed a
high A1T content (70%), and revealed several inverted repeat
sequences and a putative integration host factor-binding con-
sensus motif (Fig. 2), which might be involved in the control of
gene expression. Although these potential regulatory elements
are present in Pa424, they are absent in Pa255. Transcription of
paaX (Fig. 6D) starts 29 nucleotides upstream of the ATG
translation initiation codon (Fig. 2). The presence in the Px
promoter of a putative extended 210 box (TGCTATGAT) could
explain the absence of a consensus 235 hexamer (Fig. 2). It is
worth noting that the putative stem-loop structure that could
act as a transcriptional terminator of the paaABCDEFGHIJK
operon is located only 15 bp upstream from the extended 210
box of the Px promoter (Fig. 2).
We have shown above that expression of the paa catabolic
operon is controlled by the paaX gene product; therefore, to
FIG. 4. Schematic representation of
the subcloning and expression of dif-
ferent paa genes. Plasmids are drawn
with the relevant elements and restric-
tion sites indicated. DNA containing the
paa genes from E. coli W is represented
with a black box. Vector-derived se-
quences are indicated with continuous
(pUC derivatives) or discontinuous
(pCK01 derivatives) lines. Arrows show
the Plac promoter and the direction of
transcription of the genes. Plasmid con-
structs derived from pAAD (A) and
pAAD::Tn1000 derivative 10 (B), are
shown. g and d, the gamma and delta
ends of transposon Tn1000, respectively.
Apr and Cmr, the genes that confer ampi-
cillin and chloramphenicol resistance, re-
spectively. Restriction sites are: B, BglII;
Ba, BamHI; Bs, BsrGI; E, EcoRI; Ev,
EcoRV; H, HindIII; N, NotI; P, PstI; S,
SphI; Sm, SmaI; X, XbaI. B*, additional
BglII restriction sites are present in the
sequence of transposon Tn1000.















further analyze faithfully this regulatory system, we have en-
gineered the reporter Pa-lacZ fusion within a mini-Tn5 vector
(Fig. 5). The resulting constructions, pAFPA1T (Pa424-lacZ)
and pAFPA2T (Pa255-lacZ) were used to deliver by transposi-
tion the corresponding translational fusions into the chromo-
some of E. coli AF141, a rifampicin-resistant E. coli W14
(lacZ2) mutant strain devoid of b-galactosidase activity, giving
rise to the reporter strains E. coli AF1411 and AF1412, respec-
tively. The presence of a strong T7 phage transcriptional ter-
minator downstream of the lacZ fusions and their orientation
within the mini-Tn5 elements (Fig. 5), prevented read-through
transcription from nearby chromosomal promoters after inser-
tion, thus facilitating the regulatory studies. To check the
influence of the PaaX protein on the expression of the reporter
fusions, paaX was cloned in plasmid pAFX2 (Fig. 7) and ex-
pressed into the reporter strains. The b-galactosidase assays of
permeabilized E. coli AF1411 and AF1412 cells harboring
control plasmid pCK01 showed a similar and constitutive
expression of the reporter fusions (Table IV). When the gene
paaX was expressed in trans, we observed a drastic decrease
(more than 2 orders of magnitude) in the b-galactosidase
levels of E. coli AF1411 (pAFX2) and E. coli AF1412 (pAFX2)
cells (Table IV), thus indicating that PaaX behaves as a
transcriptional repressor of Pa both in the Pa424 and Pa255
promoter fragments.
The repressor effect of PaaX on Pa could not be significantly
alleviated by growing the cells in the presence of 5 mM PA
(Table IV), which indicates that this aromatic compound is not
the true inducer of the pathway. Interestingly, when the paaK
and paaX genes were simultaneously expressed in the reporter
strains, b-galactosidase activities were shown to be inducible
by 5 mM PA (Table IV), suggesting that the reaction product of
the PaaK enzyme, i.e. PA-CoA, is the inducer of the Pa pro-
moter. Furthermore, it is worth noting that Pa424 and Pa255
responded similarly to the PaaX-mediated regulation, thus
suggesting that the 169-bp region that is absent in Pa255 is not
directly involved in the promoter-operator sites of the paa
catabolic operon.
DISCUSSION
In this report, we describe the molecular characterization of
the PA catabolic pathway of E. coli. Previous work had shown
that, whereas E. coli K-12 and E. coli W were able to grow on
PA as the sole carbon source, this catabolic ability was lacking
in E. coli C (2). The molecular analysis presented here confirm
the previous observations, indicating that a 33.3-kb DNA frag-
ment that appears to contain the paa genes responsible of the
PA catabolism in E. coli W is lacking in E. coli C as well as in
the mutant strain E. coli W14. However, we have shown here
that the ability of E. coli K-12 to grow on PA was strain-de-
pendent, with point mutations or small gene rearrangements
being the most probable reason for the PA2 phenotype of some
K-12 laboratory strains such as DH5a, HB101, and DH1.
The paa genes from E. coli W were located in a chromosomal
15.4-kb DNA fragment cloned in plasmid pAAD, and they
mapped at the right end of the mao region (Fig. 1A), which is
involved in the transformation of 2-phenylethylamine into PA
(18, 37, 38). As the equivalent mao genes in E. coli K-12 have
been mapped at min 31.0 on the chromosome (43), and two PA2
mutants of E. coli K-12 had been located in this chromosomal
region (7), a similar location of the paa genes in the chromo-
some of E. coli W can be suggested.
The nucleotide sequence of the paa cluster revealed the
presence of 14 ORFs, paaZpaaABCDEFGHIJKpaaXY (Figs. 1
and 2), that corresponded with those of unknown function
whose Protein Identification Database accession numbers are
g1787653–g1787664, g1787666, and g1787667, respectively,
and that have been recently sequenced in E. coli K-12 (acces-
sion numbers AE000236, AE000237, D90777, and D90778)
(41). Although the left end of the paa cluster was near to the
maoA gene both in E. coli W and K-12, the right end of the paa
cluster was different in the two strains. Thus, although the
paaY stop codon was found 231 bp upstream of the ATG start
codon of the ydbC gene in E. coli W (Fig. 2), a 9.2-kb sequence
encoding a long ORF (ydbA) disrupted by two insertion se-
quences (IS2 and IS30) was found between paaY (Protein Iden-
tification Database accession number g1787667) and ydbC in
E. coli K-12 (29). The presence of insertion sequences near the
paa cluster and the location of this cluster in a nonessential
region of the chromosome (44) provide some clues on the pos-
sible mechanisms of gene mobilization of a catabolic cassette
that would enhance bacterial adaptability, and could explain
the heterogeneity observed among different E. coli strains re-
spect to their ability to mineralize PA. It is also noteworthy
that the mao genes for the metabolism of 2-phenylethylamine,
an aromatic amine whose degradation gives rise to PA, lie
adjacent to the paa cluster responsible for the further catabo-
lism of PA. This association between genes belonging to the
same catabolon (15), i.e. genes involved in convergent degrada-
tive routes, could be considered as an important evolutionary
and adaptive advantage. Another example of such association
within a PA catabolon has been recently described in the path-
TABLE II
PA-CoA ligase activity of E. coli W14 recombinant strains
Enzymatic activities were assayed using crude extracts of E. coli W14
containing different plasmids. Cells were grown in glycerol-containing
minimal medium in the presence of 5 mM PA. Enzymatic assays were
performed as described under “Experimental Procedures.” Results of
one experiment are given; values were reproducible in three separate
experiments.
E. coli W14




None paa cluster absent BDa
pAAD Wild-type paa cluster 22
pAAD::Tn1000 40 paaZ 30
pAAD::Tn1000 3 paaZ 55
pAAD::Tn1000 21 paaZ 59
pAAD::Tn1000 35 paaB 6
pAAD::Tn1000 59 paaC 5
pAAD::Tn1000 24 paaD 5
pAAD::Tn1000 83 paaE 5
pAAD::Tn1000 86 paaF 5
pAAD::Tn1000 16 paaG 5
pAAD::Tn1000 45 paaJ 6
pAAD::Tn1000 46 paaK BD
pAAD::Tn1000 6 paaX 27
pAAD::Tn1000 32 paaX 20
pAAD::Tn1000 84 paaY 16
a BD, below detection limits.
TABLE III
Analysis of the paaK expression
E. coli W14 cells containing different plasmids were grown in glycer-
ol-containing minimal medium in the absence (uninduced) or presence
of 5 mM PA (induced). Preparation of cellular extracts and determina-
tion of PA-CoA ligase activity were done as described under “Experi-
mental Procedures.” Results of one experiment are given; values were
reproducible in three separate experiments.
E. coli W14 plasmid Tn1000insertion
PA-CoA ligase activity
Uninduced Induced with 5 mM PA
units/mg protein
pAAD None BDa 18
pAAD::Tn1000 6 paaX 20 22
pAAD::Tn1000 32 paaX 15 20
pAAD::Tn1000 84 paaY BD 16
a BD, below detection limits.















way for styrene degradation in Pseudomonas sp. Y2, where the
sty genes responsible of the oxidation of styrene to PA are in
tight association with the genes involved in PA degradation
(16).3
The genetic arrangement of the paa cluster and the mu-
tagenesis of pAAD with transposon Tn1000 revealed that the
14 paa genes are organized in three transcriptional units, two
of them, paaZ and paaABCDEFGHIJK, essential for the ca-
tabolism of PA, and a third one, paaXY, that contains the paaX
regulatory gene. An overall sequence comparison analysis of
the paa gene products showed that they were homologous to
the recently described pha genes responsible of the catabolism
of PA in P. putida U (15) (Fig. 8B). Here, we have presented
experimental evidence that the paaK gene product is the PA-
CoA ligase of E. coli W (Fig. 3B), an activity that had been
3 A. Velasco, S. Alonso, J. Perera, J. L. Garcı́a, and E. Dı́az, unpub-
lished data.
FIG. 5. Schematic representation of
the construction of lacZ transla-
tional fusion cassettes. The PCR-am-
plified promoter regions (detailed under
“Experimental Procedures”) cloned in the
promoter-probe plasmid pSJ3 are shown.
The promoterless lacZ reporter gene is
indicated with a thick arrow. The promot-
ers and the direction of transcription of
the genes are represented with white and
black thin arrows, respectively. D, a trun-
cated gene. The number of amino acid
residues fused to the LacZ protein is indi-
cated in parentheses. The white box rep-
resents the early T7 transcriptional ter-
minator (19). The I and O termini of the
hybrid mini-Tn5 transposons are also in-
dicated. Apr and Kmr, the genes that con-
fer ampicillin and kanamycin resistance,
respectively. tnp*, gene devoid of NotI
sites encoding the Tn5 transposase. Re-
striction sites are: B, BamHI; E, EcoRI; H,
HindIII; K, KpnI; N, NotI; S, SphI; Sm,
SmaI; Ss, SspI; X, XbaI.
FIG. 6. Identification of the 5* tran-
scription start sites in the Pa, Px, and
Pz promoters. Total RNA was isolated
from E. coli CC118 cells bearing the lacZ
translational fusion plasmids pAFPA1 (A
and B, lane 2), pAFPZ (C, lane 2), and
pAFPX (D, lane 2), and the control plas-
mid pSJ3 (lane 1 in the four panels), as
described under “Experimental Proce-
dures.” The sizes of the extended products
were determined by comparison with the
DNA-sequencing ladder of the Pa (A and
B), Pz (C), and Px (D) promoter regions (A,
C, G, and T), using plasmids pAFPA1,
pAFPZ, and pAFPX as the templates, re-
spectively. Primer extension and sequenc-
ing reactions were performed with prim-
ers LAC-57 (A, C, and D), and PA5–4 (B),
as described under “Experimental Proce-
dures.” To the right of each panel, an ex-
panded view of the nucleotide sequence
surrounding the transcription initiation
site(s) (*) is shown. Note that the se-
quence corresponds to the coding strand
(Fig. 2).















detected in this strain when it was grown in PA-containing
medium (13). Analysis of the primary structure of PaaK (Fig. 2)
revealed that residues 103SSGTTGKPTV112 match the AMP-
binding site consensus sequence T(SG)-S(G)-G-(ST)-T(SE)-
G(S)-X-P(M)-K-G(LAF) in acyl-adenylate-forming enzymes
(residues that predominate at that position are underlined,
with alternates given in parentheses; X represents a hypervari-
able position) (45). It is worth noting that the Lys residue of
this signature motif is substituted by Thr in all phenylacetyl-
CoA ligases so far sequenced, i.e. PaaK, PhaE (12) and
PaaK_Y2 (16), an observation that supports recent studies
showing that this residue does not assume a major role in ATP
binding (45). The sequences 236DIYGLSE242 and 302YRTRD306
(underlined are the stringently conserved residues) in PaaK
also match the conserved motifs II and III that may contribute
to the substrates binding sites in acyl-adenylate-forming
enzymes (45).
The detection of radiolabeled PA-CoA inside E. coli W14
(pAAD::Tn1000 derivative 3) cells, indicates that disruption of
the paaZ gene causes a blockade of the PA catabolic pathway
leading to the accumulation of this CoA derivative, and con-
firms the physiological role of PaaK in the catabolism of PA in
this microorganism. Assuming that the paaK gene product
catalyzes the first enzymatic step of the PA catabolic pathway,
the polar effects caused by the Tn1000 insertions within the
potential paa catabolic operon containing the paaK gene at its
39-end, can explain why pathway intermediates did not accu-
mulate in E. coli W14 cells expressing the corresponding
pAAD::Tn1000 derivatives. The degradation of PA in P. putida
U also appears to require PA-CoA as the first intermediate of
the pathway (12), and a similar situation could be inferred in
other bacteria that are able to use aerobically PA as the sole
carbon source (13, 16). The aerobic catabolism of aromatic
compounds via their initial activation to CoA derivatives con-
stitutes an unusual strategy that resembles anaerobic degra-
dation mechanisms (46), and could be a widespread way of PA
catabolism in bacteria. The participation CoA ligases in the
initial step of the aerobic catabolism of 2-aminobenzoate (47)
and benzoate (48) in Azoarcus evansii KB740 (formerly Pseudo-
monas sp. KB740), ferulate in P. putida (49) and Pseudomonas
fluorescens (50), and 2-furoic acid in P. putida Fu1 (51) has
been also reported, and the existence of a CoA ligase has been
suggested for the aerobic catabolism of salicylate in Rhodococ-
cus sp. strain B4 (52) and thiophen-2-carboxylate (53). More-
over, some dehalogenation mechanisms of aromatic compounds
also involve CoA thioester formation in aerobiosis (54). Al-
though the rationale for utilizing such hybrid pathways, i.e.
aerobic catabolic pathways endowed with typical features of an
anaerobic catabolism, is not known, it has been suggested that
they could represent a strategy of facultative microorganisms
to cope with the fluctuations of oxygen supply (55). In this
sense, the existence of a hybrid pathway for the catabolism of
PA in E. coli could reflect the facultative anaerobe character of
this bacterium.
All or some of the paaABCDE genes appear to be responsible
of the second enzymatic step in the catabolism of PA in E. coli.
Thus, the expression of paaK and paaABCDE genes in E. coli
W14 caused the consumption of PA and the accumulation of
2-HPA in the culture medium. However, 2-HPA appears not to
be a true intermediate in the PA catabolic pathway as it does
not support growth of E. coli W and is not consumed even when
E. coli W cells are growing also in the presence of PA. Inter-
estingly, a similar lack of growth on 2-HPA and accumulation
of this compound after adding PA to some cultures of PA2
mutant strains from E. coli K-12 (7) and P. putida U (15), has
been also observed. Although the possibility that exogenous
2-HPA does not enter the cells cannot be ruled out, the fact that
2-HPA formation requires the simultaneous expression of the
paaK and paaABCDE genes strongly suggests that 2-HPA is
not a true intermediate in PA degradation but derives from the
accumulation of a hydroxylated PA-CoA intermediate that can-
not be further degraded. The excretion to the culture medium
of a hydroxylated aromatic compound as a dead-end product
derived from the intracellular accumulation of a hydroxylated
CoA derivative has been also reported in the hybrid pathway
for the catabolism of 2-aminobenzoate (47), and could be a
general strategy of the cells to prevent the possible metabolic
risk of depletion of the intracellular pool of CoA (15, 56).
The second catabolic step in PA degradation in E. coli seems
to be, therefore, the hydroxylation of PA-CoA. Although we
could not detect a hydroxylated CoA derivative in E. coli W14
(pAAD::Tn1000 derivative 3) cells, intracellular accumulation
of 2-HPA-CoA has been observed during the catabolism of PA
by a PA- P. putida U mutant strain (15). Sequence comparison
analyses of the paaABCDE gene products revealed that the
PaaE protein (356-amino acid length) showed significant sim-
ilarity with the class IA-like reductases (Table I). These en-
zymes are members of the ferredoxin-NADP1 reductase (FNR)
family and they contain a FNR-like domain consisting of a
FMN(FAD)- and a NAD(P)-binding region (57). The residues
55RCYS58 in PaaE fit the RXYS consensus motif for binding of
the isoalloxazine ring of the flavin cofactor, and residues 121GS-
GITP126 and 216CGPAAM221 match the GXG(X)2–3P and
CG(X)3–4M sequences for the binding of the NAD(P) ribose and
NAD(P)-pyrophosphate-nicotinamide moieties of the nicotin-
amide cofactor, respectively (58). At the C terminus of the
FNR-like domain, residues 299–337 in PaaE correspond to the
CX4CXXCX24–34C conserved motif of the plant-type ferredoxin
[2Fe-2S] binding domain (58). Other members of the extended
FNR family are the reductase components of the methane,
alkene, phenol, and toluene diiron monooxygenases (59–63), a
group of bacterial hydrocarbon oxidation enzymes that com-
FIG. 7. Subcloning and expression of the paaX regulatory
gene. Plasmids are drawn with the relevant elements and restriction
sites indicated. Plasmid pFH55-P has been described in Fig. 1A. Vector-
derived sequences are indicated with continuous (pUC derivatives) or
discontinuous (pCK01 derivatives) lines. Arrows show the Plac pro-
moter and the direction of transcription of the genes. The bent arrows
indicate the Px promoter. Apr and Cmr, the genes that confer ampicillin
and chloramphenicol resistance, respectively. D, a truncated gene. Re-
striction sites are: Ba, BamHI; Bc, BclI; E, EcoRI; Ec, Eco47III; H,
HindIII; Hc, HincII; N, NotI; P, PstI.















prises an evolutionarily related protein family (60). These sol-
uble multicomponent monooxygenases contain, in addition to
the reductase component, a heteromultimeric (abg) oxygenase
component, a low molecular weight activator protein (61–63),
and, in some cases, a Rieske-type ferredoxin (59, 60). Interest-
ingly, the primary structure of the PaaA protein (309-amino
acid length) shows the two repeats of residues EX2H separated
by approximately 100 amino acids (positions 155–158 and 249–
252) that characterize the dinuclear iron binding-site of the
large (a) oxygenase subunit of the methane, phenol, and tolu-
ene diiron monooxygenases (60). Moreover, the amino acid
sequence of PaaB (95-amino acid length) shows the strictly
conserved residues found in the low molecular weight disso-
ciable activator protein that is required for optimal turnover of
the oxygenase component in multicomponent diiron monooxy-
genases (64). Therefore, these sequence comparison analyses
suggest that genes paaABCDE may encode the five subunits of
a diiron multicomponent oxygenase, with PaaB being the ef-
fector protein and PaaE the reductase that mediates electron
transfer between NAD(P)H and the PaaACD oxygenase com-
ponent. It is worth noting that the paaE gene product can
constitute the first example of a reductase subunit from a
multicomponent oxygenase that shows a reversed domain or-
der, i.e. a FNR-like N-terminal domain and a plant-type ferre-
doxin C-terminal domain, which supports the previous hypoth-
esis that class IA-like reductases may have been recruited for a
variety of aromatic ring oxidation reactions (65). Moreover, the
putative PaaABCDE oxygenase, and its counterpart encoded
by the phaFGHI operon of P. putida U (Fig. 8B), may represent
the first reported multicomponent oxygenase acting on a CoA-
activated aromatic acid.
The paaZ gene product appears to be responsible of the third
enzymatic step of the PA catabolic pathway. The putative PaaZ
protein (681-amino acid length) presents an N-terminal region
(residues 1–527) whose primary structure shows similarity
with that of aldehyde dehydrogenases (Table I). In this sense,
the PaaZ residues 229FTGSAATG236 and 291GQKCTAIR298, re-
spectively, match the consensus NAD(P)1-binding site and the
active site motif spanning the catalytic cysteine (underlined) of
aldehyde dehydrogenases (18, 66). Moreover, the sequence
254MEADSLN260 in PaaZ encompasses the potential catalytic
glutamic acid residue (italicized) of aldehyde dehydrogenases
(18, 66). The amino acid sequence of the C-terminal region of
PaaZ shows similarity to that of the maoC and nodN gene
products of unknown function (Table I). As has been suggested
for the analogous PhaL protein of P. putida U (15) (Fig. 8B), the
paaZ gene product in E. coli might catalyze the aromatic ring
cleavage of the hydroxylated CoA derivative formed during PA
degradation. Nevertheless, the formation by PaaZ of a non-
aromatic CoA cyclic intermediate, similar to that described as
the product of the reaction catalyzed by the aminobenzoyl-CoA
monooxygenase-reductase during the aerobic catabolism of
2-aminobenzoate (67), cannot be ruled out.
The paaF, paaG, paaH, and paaJ gene products show sig-
nificant sequence similarities to fatty acid b-oxidation enzymes
(Table I), and therefore can tentatively constitute a b-oxida-
tion-like pathway involved in the successive oxidation reac-
tions of the non-aromatic CoA intermediate. Interestingly, a
TABLE IV
Regulation of expression from the Pa promoter by PaaX
E. coli strains were grown in glycerol-containing minimal medium in the absence (uninduced) or in the presence of 5 mM PA (induced).
b-Galactosidase activities were measured with permeabilized cells as described under “Experimental Procedures.” Results of one experiment are





b-Galactosidase activity (Miller units)
Uninduced Induced(5 mM PA) -Fold induction
AF141 None lacZ2 BDa BD
AF1411 pCK01 Pa424::lacZ 3111 4156 1.3
AF1411 pAFX2/paaX Pa424::lacZ 10 46 4.6
AF1411 pAFX2/paaX Pa424::lacZ 12 1114 93
pAFK5/paaK
AF1412 pCK01 Pa255::lacZ 3441 3877 1.1
AF1412 pAFX2/paaX Pa255::lacZ 16 59 3.6
AF1412 pAFX2/paaX Pa255::lacZ 25 1737 69
pAFK5/paaK
a BD, below detection limits.
FIG. 8. Comparison of the paa clus-
ter of E. coli W with the pha cluster of
P. putida U. A, comparison of the genetic
organization of the paa and pha clusters.
Blocks with similar shading or hatching
indicate homologous regions encoding po-
tential functional units in both gene clus-
ters. The location and size of the inter-
genic regions, are also indicated. Bent
arrows represent the promoters. B, per-
centages of amino acid sequence identity
between the analogous paa and pha gene
products. Note that genes phaJK do not
have counterparts in the paa cluster, and
that genes paaB and paaI have not been
described in the pha cluster.















b-oxidation-like mechanism is another typical feature of the
anaerobic catabolism of aromatic compounds (46). The primary
structure of the putative PaaF (255-amino acid length) and
PaaG (262-amino acid length) proteins shows similarity with
that of members of the enoyl-CoA hydratase/isomerase super-
family (54, 68) (Table I). The paaH gene encodes a protein
(475-amino acid length) that shares the signature sequence
motives of 3-hydroxyacyl-CoA dehydrogenases (69) (Table I),
thus suggesting that it could attack the product of the reaction
catalyzed by the PaaF and PaaG enzymes. Although the paaI
gene product (140-amino acid length) did not show a high level
of sequence similarity with other proteins in the data bases, the
paaJ gene product (401-amino acid length) presented a signif-
icant sequence similarity with the PcaF and CatF b-ketoadipyl-
CoA thiolases (Table I), residues 90 and 386 in PaaJ being the
putative catalytic cysteines. As PcaF and CatF catalyze the last
step in the ortho-cleavage pathway for the aerobic degradation
of protocatechuate and catechol, respectively (70), it is tempt-
ing to speculate that PaaJ and its analogous PhaD protein in P.
putida U (Fig. 8) are also responsible for the last enzymatic
step in PA degradation.
In the paa cluster, we have identified three promoters, Pz,
Pa, and Px, which drive the expression of genes paaZ, paaAB-
CDEFGHIJK, and paaXY, respectively (Figs. 6 and 8A). The
expresion of the paa-encoded catabolic pathway is inducible,
and it has been shown that the Pa promoter is negatively
controlled by the paaX gene product (Table III and IV). The
PaaX protein (316-amino acid length) contains a stretch of 25
residues at amino acids 39–64 that shares similarity with the
helix-turn-helix motif predicted to be important for DNA rec-
ognition and binding in other transcriptional repressors such
as GntR (71) and FadR (72). The GntR and FadR binding sites
within the respective promoters contain a region of dyad sym-
metry, which is located very close to the transcription initiation
sites (71–73). Interestingly, a region of dyad symmetry can also
be found centered near the transcription initiation sites in the
Pa promoter (Fig. 2). As the repression caused by PaaX was
only alleviated by PA in the presence of the PaaK protein
(Table IV), PA-CoA appears to be the true inducer of the paa-
encoded pathway. In this sense, gel retardation assays have
confirmed PA-CoA as the effector molecule.4 Therefore, PaaX
constitutes the first reported transcription factor regulated by
CoA derivatives that controls the catabolism of aromatic com-
pounds. It is worth noting that the FadR transcriptional re-
pressor, which is regulated by acyl-CoA compounds and shows
local similarity to PaaX, is also controlling the expression of
genes involved in b-oxidation mechanisms (73).
Overlapping the 39-end of paaX, we have found the putative
ATG translation initiation codon of the paaY gene. A palin-
dromic sequence (DG value of 215.7 kcal/mol) followed by a (T)7
tract is located 42 bp downstream of the TAA stop codon of
paaY (Fig. 2), and may act as a r-independent transcription
terminator of the putative paaXY operon. Although the pri-
mary structure of the paaY gene product (196-amino acid
length) and its analogous PhaM protein from P. putida U (Fig.
8B) show several repeats of the hexapeptide (LIV)GX4 motif
that characterizes the members of the bacterial transferases
family, e.g. the CaiE protein from the carnitine operon of E. coli
and the Fbp ferripyochelin-binding protein of P. aeruginosa
(Table I), the physiological role of these proteins in PA catab-
olism is still unknown.
Comparative studies of the whole structure and organization
of the paa and pha clusters from E. coli and P. putida U,
respectively (Fig. 8A), revealed interesting functional and evo-
lutionary data. Thus, although the pha genes appear to be
cotranscribed in four discrete DNA segments or modules en-
coding the six different functional units for the catabolism of
PA, i.e. the b-oxidation and activation (phaABCDE), hydroxy-
lation (phaFGHI), transport and dearomatization (phaJKL),
and regulation (phaMN) units, the paa cluster showed the
transcriptional coupling of the hydroxylation-b-oxidation-acti-
vation functional units into the single operon paaABCDEF-
GHIJK (Fig. 8A). As there is good evidence that operons coding
for the catabolism of aromatic compounds are assembled in a
stepwise manner from existing catabolic genes (74), it is tempt-
ing to speculate that the paa cluster from E. coli arose by the
fusion of some gene blocks that are contiguous but separately
regulated in the pha cluster of P. putida U, and therefore it
could be considered as a further step in the evolution toward a
single regulon of a common ancestral gene cluster involved in
PA catabolism. Moreover, the differences in gene order within
some of the DNA modules, and the relative locations of these
modules in the paa and pha clusters, suggest that various DNA
rearrangements have occurred during their evolution. As the
G1C content of the paa (52.5%) and pha (63.5%) genes aver-
aged a value close to the mean G1C content of E. coli (51.5%)
and P. putida (60%) genomic DNA (40), it could be thought that
these two set of genes have been imprisoned within each host
over a long period of evolution. Especially remarkable is the
observation that the phaJ and phaK genes of P. putida U,
encoding a permease and a specific-channel-forming protein for
the uptake of PA, respectively (15), are absent in the paa
cluster from E. coli W (Fig. 8A). Interestingly, the phaJ gene
product shows significant amino acid sequence identity (62.1%)
with the product of the yjcG gene that is located at min 92.2 of
the E. coli K-12 chromosome (29). Whether a permease, such as
the putative YjcG protein, and a channel-forming protein are
required for the catabolism of PA in E. coli is still an open
question.
The identification and genetic characterization of the hybrid
paa-encoded pathway complete our knowledge on the pathways
so far described for the aerobic catabolism of aromatic com-
pounds in E. coli. Although, in some Pseudomonas and Acin-
etobacter species, a supraoperonic clustering of the aromatic
catabolic genes has been observed in a limited region of the
chromosome, the aromatic catabolic clusters are dispersed
throughout the genome in E. coli, with cluster mhp (3-(3-hy-
droxyphenyl)propionate and 3-hydroxycinnamate) at min 8 (1,
10), paa at min 31, hca (3-phenylpropionate) at min 57.5 (11),
and hpa (3- or 4-hydroxyphenylacetate) at min 98 (8). These
data also indicate that E. coli is not an “empty box” for the
catabolism of aromatic compounds; on the contrary, it is en-
dowed with typical aerobic degradation routes as well as with
a novel hybrid pathway, which are considered among the most
ubiquitous aromatic compound catabolic systems and therefore
are thought to be closer to the central catabolism than those
involved in the degradation of xenobiotic compounds (75).
The results presented in this work provide a framework for
additional studies to determine the role and properties of the
enzymes involved in PA catabolism through a hybrid aerobic
pathway that is likely to be a widespread route for the metab-
olism of this aromatic compound. In this sense, the cloned paa
genes should be useful as probes to identify homologous genes
from distinct groups of bacteria. Moreover, we anticipate that
the unique features of the aerobic paa-encoded pathway will
reveal novel catabolic activities that can be of great biotechno-
logical interest to improve some microorganisms for the degra-
dation of PA-related aromatic environmental pollutants (e.g.,
styrene), and for the synthesis of pathway intermediates that4 A. Ferrández, J. L. Garcı́a, and E. Dı́az, manuscript in preparation.















can be useful for the production of new or modified antibiotics
and plastics (15).
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